Altered B12 handling and reduced clearance in kidney disease, and both cellular release and reduced clearance in liver disease, can raise B12, so supportive renal or hepatic findings make those causes plausible
Phase 3 studies showed approximately 18% reduction in VAT after 26 weeks of treatment, alongside improvements in liver fat (NAFLD) and lipid profile metrics
Growth hormone naturally declines with age, which can contribute to muscle loss, fat gain, poor sleep, and slower recovery
If you have very sensitive skin, we recommend performing a patch test before first use.
Patients with pernicious anaemia or complete malabsorption typically require lifelong treatment at standard intervals, while those with partial malabsorption may have variable needs
Hamidreza , based on your specific health goals, medical history, and lifestyle